NeuroPace, Inc.

NASDAQ:NPCE

6.82 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -32.956-47.082-36.08-24.278-29.973
Depreciation & Amortization 1.6052.9870.2960.3120.421
Deferred Income Tax 4.41405.4780.187-0.944
Stock Based Compensation 9.5588.3494.2881.3791.442
Change In Working Capital -2.484-4.7880.368-2.0670.009
Accounts Receivables -4.85-0.3911.304-2.378-0.75
Inventory -1.698-2.133-1.1560.672-1.638
Accounts Payables 0.240.6470.479-0.005-0.082
Other Working Capital 3.824-2.911-0.259-0.3562.479
Other Non Cash Items 0.1623.6651.0732.8584.019
Operating Cash Flow -19.701-36.869-24.577-21.609-25.026
Investing Activities:
Investments In Property Plant And Equipment -0.173-0.603-0.384-0.062-0.468
Acquisitions Net 00010.7050.004
Purchases Of Investments 00-85.012-17.005-18.018
Sales Maturities Of Investments 23.224.406.322.1
Other Investing Activites 23.224.4-85.012-10.7054.086
Investing Cash Flow 23.02723.797-85.396-10.7673.618
Financing Activities:
Debt Repayment 00-4.09-42.12-21.328
Common Stock Issued 8.3860.896109.08931.4970.042
Common Stock Repurchased -0.259-0.059000
Dividends Paid 00000
Other Financing Activities -0.259-0.347-2.47365.63242.656
Financing Cash Flow 8.1270.49102.52655.00921.37
Other Information:
Effect Of Forex Changes On Cash 00000
Net Change In Cash 11.453-12.582-7.44722.633-0.038
Cash At End Of Period 18.0586.72719.30926.7564.123